Neil Bifulco

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

Margit Hagel, Chandra Miduturu, Michael P. Sheets et al. · Cancer Discovery · 2015 · 305 citations · Full text

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 262 citations

Bacterial Resistance, Antimicrobial Susceptibility, Health Sciences +12

Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma

Megan Hatlen, Oleg Schmidt-Kittler, Cori Ann Sherwin et al. · Cancer Discovery · 2019 · 106 citations

The design, synthesis and activity of non-ATP competitive inhibitors of pp60c-src tyrosine kinase. Part 2: Hydroxyindole derivatives

Karen L. Milkiewicz, Thomas H. Marsilje, Richard P. Woodworth et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 30 citations · Full text

Hydroxyindole Derivatives, Pp60c-src Tyrosine Kinase, Medicinal Chemistry +12

Substituted indanylacetic acids as PPAR-α–γ activators

Derek Lowe, Neil Bifulco, William H. Bullock et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 14 citations · Full text

Derivative (Chemistry), Indanylacetic Acids, Organic Chemistry +3